5.435
price up icon0.18%   0.005
 
loading
전일 마감가:
$5.43
열려 있는:
$5.37
하루 거래량:
666.31K
Relative Volume:
0.61
시가총액:
$916.40M
수익:
$596.48M
순이익/손실:
$123.72M
주가수익비율:
9.9106
EPS:
0.5484
순현금흐름:
$106.59M
1주 성능:
+1.49%
1개월 성능:
+21.70%
6개월 성능:
+59.53%
1년 성능:
+63.36%
1일 변동 폭
Value
$5.37
$5.44
1주일 범위
Value
$5.30
$5.45
52주 변동 폭
Value
$2.37
$5.72

큐어백 Stock (CVAC) Company Profile

Name
명칭
Curevac N V
Name
전화
-
Name
주소
-
Name
직원
1,088
Name
트위터
Name
다음 수익 날짜
2025-04-10
Name
최신 SEC 제출 서류
Name
CVAC's Discussions on Twitter

CVAC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CVAC
Curevac N V
5.435 916.40M 596.48M 123.72M 106.59M 0.5484
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
456.25 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.21 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.42 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
555.31 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
246.33 28.51B 3.81B -644.79M -669.77M -6.24

큐어백 Stock (CVAC) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-13 다운그레이드 Jefferies Buy → Hold
2024-04-25 다운그레이드 Leerink Partners Outperform → Market Perform
2023-06-08 개시 SVB Securities Outperform
2023-01-19 업그레이드 UBS Neutral → Buy
2023-01-09 업그레이드 Jefferies Hold → Buy
2022-01-21 다운그레이드 BofA Securities Neutral → Underperform
2022-01-18 개시 JMP Securities Mkt Outperform
2021-10-22 개시 Deutsche Bank Hold
2021-06-17 다운그레이드 BofA Securities Buy → Neutral
2021-04-26 재개 Credit Suisse Underperform
2021-04-26 개시 Guggenheim Neutral
2020-12-10 다운그레이드 Credit Suisse Neutral → Underperform
2020-09-08 개시 BofA Securities Buy
2020-09-08 개시 Credit Suisse Neutral
2020-09-08 개시 Jefferies Hold
모두보기

큐어백 주식(CVAC)의 최신 뉴스

pulisher
Jun 18, 2025

Private-Public Deal Momentum Grows, Yet Megamergers Stay Elusive - Investing.com

Jun 18, 2025
pulisher
Jun 17, 2025

BioNTech SE Announces Acquisition of CureVac N.V. - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Germany: BioNTech to acquire CureVac in all-stock transaction - Investors in Healthcare

Jun 17, 2025
pulisher
Jun 16, 2025

BioNTech to Acquire CureVac in Strategic Move - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

CureVac agrees to pay Biontech termination fee Of $43.8 mln under specified circumstances - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

5 Stocks To Ride The German Market RallyCureVac (NASDAQ:CVAC), BioNTech (NASDAQ:BNTX) - Benzinga

Jun 16, 2025
pulisher
Jun 15, 2025

BioNTech to Acquire CureVac in US$1.25 Billion All-Stock Transaction - Global Legal Chronicle

Jun 15, 2025
pulisher
Jun 15, 2025

There's No Escaping CureVac N.V.'s (NASDAQ:CVAC) Muted Revenues Despite A 50% Share Price Rise - simplywall.st

Jun 15, 2025
pulisher
Jun 14, 2025

CureVac’s SWOT analysis: mRNA pioneer’s stock faces pivotal year ahead By Investing.com - Investing.com Nigeria

Jun 14, 2025
pulisher
Jun 13, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVAC, KNW, SOAR, HLGN on Behalf of - Bluefield Daily Telegraph

Jun 13, 2025
pulisher
Jun 13, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVAC, KNW, SOAR, HLGN on Behalf of Shareholders - TradingView

Jun 13, 2025
pulisher
Jun 13, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Jun 13, 2025
pulisher
Jun 13, 2025

BioNTech CureVac Acquisition Boosts Cancer Drug Pipeline - Industry Leaders Magazine

Jun 13, 2025
pulisher
Jun 13, 2025

CureVac (CVAC) Receives Downgrade and Price Target Reduction fro - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer - GlobeNewswire

Jun 13, 2025
pulisher
Jun 13, 2025

Jefferies cuts CureVac stock rating to hold on BioNTech acquisition By Investing.com - Investing.com UK

Jun 13, 2025
pulisher
Jun 13, 2025

BioNTech: Oddo BHF raises target price - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

BioNTech to buy CureVac in USD 1.25 billion all-stock deal - Medical Dialogues

Jun 13, 2025
pulisher
Jun 13, 2025

CureVac Stock: BioNTech's Billion-Dollar Takeover Bid - sharewise

Jun 13, 2025
pulisher
Jun 12, 2025

BioNTech (BNTX) to Acquire CureVac in $1.25 Billion All-Stock De - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

CureVac (CVAC) Downgraded by Jefferies Analyst After BioNTech Acquisition Agreement | CVAC Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech Announces Strategic Transaction to Acquire CureVac in P - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech Announces Strategic Acquisition of CureVac - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Biontech’s $1.25B Curevac buyout removes mRNA lawsuit uncertainty - BioWorld MedTech

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech to Acquire CureVac in $1.25B Deal - USA Herald

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech's Acquisition Of CureVac Brings Complementary Method To Target Cancer (BNTX) - Seeking Alpha

Jun 12, 2025
pulisher
Jun 12, 2025

5 Firms Guide $1.25B BioNTech, CureVac Oncology Deal - Law360

Jun 12, 2025
pulisher
Jun 12, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVAC, SOAR, MTWO on Behalf of Shareholders - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech to acquire CureVac in $1.25 billion all-stock deal By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech to Acquire CureVac to Expand mRNA Cancer Therapies - N24.com.tr

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech buys mRNA, courtroom rival CureVac in all-stock deal - BioPharma Dive

Jun 12, 2025
pulisher
Jun 12, 2025

Watkins Advises on BioNTech’s US$1.25 Billion Acquisition of CureVac - Latham & Watkins LLP

Jun 12, 2025
pulisher
Jun 12, 2025

M&A News: BioNTech (BNTX) Acquires CureVac in $1.25 Billion Deal - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

CureVac Stock Soars on BioNTech Buyout - Schaeffer's Investment Research

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal - Benzinga

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech Buys CureVac For $1.25 Billion In Stock Deal - Finimize

Jun 12, 2025
pulisher
Jun 12, 2025

CureVac, TELUS International, Oracle And Other Big Stocks Moving Higher On Thursday - Benzinga

Jun 12, 2025
pulisher
Jun 12, 2025

COVID-19 Vaccine Maker BioNTech Buys CureVac as It Aims for Cancer Treatments - Investopedia

Jun 12, 2025
pulisher
Jun 12, 2025

CureVac’s SWOT analysis: mRNA pioneer’s stock faces pivotal year ahead - Investing.com

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech takes over CureVac in $1.25 billion all-stock deal among COVID rivals - marketscreener.com

Jun 12, 2025
pulisher
Jun 12, 2025

Vaccine developer with Boston HQ acquired for $1.25B - NBC Boston

Jun 12, 2025
pulisher
Jun 12, 2025

CureVac's SWOT analysis: mRNA pioneer's stock faces pivotal year ahead By Investing.com - Investing.com India

Jun 12, 2025
pulisher
Jun 12, 2025

Sector Update: Health Care Stocks Lean Lower Premarket Thursday - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech to Buy CureVac for $1.25 Billion for Cancer Boost - Bloomberg

Jun 12, 2025
pulisher
Jun 12, 2025

M&A News: BioNTech Snaps Up CureVac in $1.25B Deal to Supercharge Cancer Pipeline - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Germany's BioNTech to buy CureVac to boost cancer research - Yahoo

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech to buy former Boston Covid vaccine rival for $1.25B - The Business Journals

Jun 12, 2025
pulisher
Jun 12, 2025

CVAC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of CureVac N.V. Is Fair to Shareholders - Business Wire

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech, CureVac Agree to All-stock Purchase Deal - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Oracle and CureVac rise premarket; Boeing and GameStop fall By Investing.com - Investing.com UK

Jun 12, 2025
pulisher
Jun 12, 2025

BioNTech to Buy CureVac in All-Stock Deal - marketscreener.com

Jun 12, 2025

큐어백 (CVAC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.00
price up icon 1.52%
$36.00
price down icon 0.06%
$21.32
price down icon 0.15%
$99.07
price down icon 1.72%
$108.80
price up icon 2.21%
biotechnology ONC
$244.86
price up icon 1.07%
자본화:     |  볼륨(24시간):